Key result
A combined abnormality in heart rate variability and QTc interval strongly predicted mortality in type 1 diabetes compared to normal values.
Why the study?
Does a combined abnormality in heart rate variability and QTc interval predict mortality in patients with type 1 diabetes?
Cohort (n=391)
Does a combined abnormality in heart rate variability and QTc interval predict mortality in patients with type 1 diabetes?
A combined abnormality in heart rate variability and QTc interval is a strong, independent predictor of mortality in patients with type 1 diabetes.
Answers are grounded in this paper and cite their sources.
May identify high-risk type 1 diabetes patients for monitoring; hypothesis-generating for interventions pending prospective trials.
OBJECTIVE: Long-term diabetes is associated with excess morbidity and mortality, and cardiovascular autonomic neuropathy and QTc interval abnormalities are both predictive of early cardiovascular death in diabetes. We aimed to investigate the effect of these risk factors in a large cohort of type 1 diabetic patients followed prospectively for 10 years. MATERIAL AND METHODS: Three-hundred-and-ninety-one type 1 diabetic mellitus patients (240 M and 151 F, age 41.8 years +/- 9.9 (mean +/-SD), duration of DM 27.3 years +/- 8.2) were followed in an outpatient setting. RESULTS: Patients with decreased heart rate variability had an excess overall mortality that diminished after adjusting for conventional cardiovascular risk factors; hazard ratio 2.5 (0.9-6.8; p = 0.071) compared to patients with normal heart rate variability. Likewise, prolonged QTc interval was associated with premature death with an adjusted hazard ratio of 2.3 (1.3-4.0; p = 0.005). In a combined analysis, patients with abnormal values for heart rate variability and QTc had a poorer prognosis compared to patients with normal test values for both parameters (adjusted hazard ratio 6.7 (1.8-25; p = 0.005)). Of the 34 patients with both test values abnormal, 15 died and 14 of these from cardiovascular causes. CONCLUSIONS: We conclude that combined abnormality in heart rate variability and QTc is a strong predictor of mortality in type 1 diabetes independently of conventional risk factors. These results have implications for future screening and treatment programmes for cardiovascular disease in type 1 diabetes.
No takes yet. Share an insight, caveat, or question.
Lykke et al. (2008) conducted a cohort in type 1 diabetes (n=391). Combined abnormality in heart rate variability and QTc interval vs. Normal test values for both parameters was evaluated on Mortality (HR 6.7, 95% CI 1.8-25, p=0.005). A combined abnormality in heart rate variability and QTc interval strongly predicted mortality in type 1 diabetes compared to normal values.
Synapse has enriched 10 related papers. Consider them for comparative context: